MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide

Georgina C Morris, Rebecca C Wiggins, Sarah C Woodhall, J Martin Bland, Carol R Taylor, Vicky Jespers, Brigitta A Vcelar, Charles J Lacey

    Research output: Contribution to journal › A1: Web of Science-article › peer-review

    48 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide'. Together they form a unique fingerprint.

    Medicine & Life Sciences